EUVIMEDEUVIMED entdecken
Crossref

CCR2 is a potential therapeutic target in peri‐implantitis

Shasha Yuan, Yiping Wei iD, Wenting Jiang, Fei Sun iD, Siqi Li iD, Qingqing Li, Zhanming Song, Zhongtian Liu, Yaqian Mo, Xuekang Wang, Ning Li, Ping Lv und 5 weitere

Journal of Clinical Periodontology · 2024

DOI: 10.1111/jcpe.13916 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Periodontology, 2024. Verfasst von Shasha Yuan und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, National Clinical Research Center for Oral Diseases, National Engineering Laboratory for Digital and Material Technolog…. Hauptthemen laut MEDLINE: Alveolar Bone Loss, Bone Resorption, Dental Implants, Peri-Implantitis. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Peking University Clinical Scientist Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

CCR2 (C‐C chemokine receptor type 2) plays a crucial role in inflammatory and bone metabolic diseases; however, its role in peri‐implantitis remains unclear. This study aimed to explore whether CCR2 contributes to peri‐implantitis and the treatment effects of cenicriviroc (CVC) on peri‐implant inflammation and bone resorption. Materials and Methods The expression of CCR2 was studied using clinical tissue analysis and an in vivo peri‐implantitis model. The role of CCR2 in promoting inflammation and bone resorption in peri‐implantitis was evaluated in Ccr2 −/− mice and wild‐type mice. The effect of CVC on peri‐implantitis was evaluated using systemic and local dosage forms.

Results

Human peri‐implantitis tissues showed increased CCR2 and CCL2 levels, which were positively correlated with bone loss around the implants. Knocking out Ccr2 in an experimental model of peri‐implantitis resulted in decreased monocyte and macrophage infiltration, reduced pro‐inflammatory cytokine generation and impaired osteoclast activity, leading to reduced inflammation and bone loss around the implants. Treatment with CVC ameliorated bone loss in experimental peri‐implantitis.

Conclusions

CCR2 may be a potential target for peri‐implantitis treatment by harnessing the immune‐inflammatory response to modulate the local inflammation and osteoclast activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alveolar Bone LossBone ResorptionDental ImplantsPeri-ImplantitisAnimalsHumansMiceCytokinesInflammationOsteoclastsReceptors, CCR2

Stichwörter der Autor:innen

bone losschemokinedental implant(s)immunityinflammation

Substanzen

CCR2 protein, humanCytokinesDental ImplantsReceptors, CCR2Ccr2 protein, mouse

Autor:innen und Institutionen

  • Department of Periodontology, National Clinical Research Center for Oral Diseases, National Engineering Laboratory for Digital and Material Technology of Stomatology, Beijing Key Laboratory of Digital Stomatology, Pekin…
  • Department of Periodontology, Tianjin Stomatological Hospital, Hospital of Stomatology, NanKai University, Tianjin, China.
  • Department of Immunology, School of Basic Medical Sciences, and NHC Key Laboratory of Medical Immunology, Peking University, Beijing, China.
  • Center for Human Disease Genomics, Peking University, Beijing, China.
  • Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Peking University People's Hospital, Beijing, China.
  • NHC Research Center of Engineering and Technology for Computerized Dentistry, Beijing, China.

ORCID-Profile: Yiping Wei, Fei Sun, Siqi Li, Wenjie Hu

Förderung

  • National Natural Science Foundation of China
  • Peking University Clinical Scientist Program

Zitieren

APA

Yuan, S., Wei, Y., Jiang, W., Sun, F., Li, S., Li, Q., Song, Z., Liu, Z., Mo, Y., Wang, X., Li, N., Lv, P., She, S., Wang, C., Zhang, Y., Wang, Y., & Hu, W. (2024). CCR2 is a potential therapeutic target in peri‐implantitis. Journal of Clinical Periodontology. https://doi.org/10.1111/jcpe.13916

Vancouver

Yuan S, Wei Y, Jiang W, Sun F, Li S, Li Q, et al. CCR2 is a potential therapeutic target in peri‐implantitis. Journal of Clinical Periodontology. 2024. doi:10.1111/jcpe.13916

BibTeX
@article{Yuan2024,
  author = {Yuan, Shasha and Wei, Yiping and Jiang, Wenting and Sun, Fei and Li, Siqi and Li, Qingqing and Song, Zhanming and Liu, Zhongtian and Mo, Yaqian and Wang, Xuekang and Li, Ning and Lv, Ping and She, Shaoping and Wang, Cui and Zhang, Yu and Wang, Ying and Hu, Wenjie},
  title = {CCR2 is a potential therapeutic target in peri‐implantitis},
  journal = {Journal of Clinical Periodontology},
  year = {2024},
  doi = {10.1111/jcpe.13916}
}
Kostenlos starten →